Impact of hepatitis C on survival in dialysis patients: a link with cardiovascular mortality?

PubWeight™: 1.05‹?› | Rank: Top 15%

🔗 View Article (PMID 22863263)

Published in J Viral Hepat on July 17, 2012

Authors

F Fabrizi1, V Dixit, P Messa

Author Affiliations

1: Division of Nephrology and Dialysis, Maggiore Hospital, IRCCS Foundation, Milano, Italy. fabrizi@policlinico.mi.it

Articles citing this

A systematic review of the impact of center volume in dialysis. BMC Res Notes (2015) 0.86

Hepatitis C virus infection and dialysis: 2012 update. ISRN Nephrol (2012) 0.85

Hepatitis C and kidney disease: An overview and approach to management. World J Hepatol (2015) 0.83

Hepatitis C Virus Infection Increases the Risk of Developing Chronic Kidney Disease: A Systematic Review and Meta-Analysis. Dig Dis Sci (2015) 0.82

Use of sofosbuvir-based direct-acting antiviral therapy for hepatitis C viral infection in patients with severe renal insufficiency. Infect Dis (Lond) (2015) 0.82

A Cross-sectional Study of the Association Between Chronic Hepatitis C Virus Infection and Subclinical Coronary Atherosclerosis Among Participants in the Multicenter AIDS Cohort Study. J Infect Dis (2015) 0.81

Hepatitis C in hemodialysis patients. World J Hepatol (2015) 0.80

Management of chronic hepatitis C virus infection in patients with end-stage renal disease: a review. Ther Clin Risk Manag (2015) 0.79

Management of hepatitis C in patients with chronic kidney disease. World J Gastroenterol (2015) 0.78

Fatty liver is associated with an increased risk of diabetes and cardiovascular disease - Evidence from three different disease models: NAFLD, HCV and HIV. World J Gastroenterol (2016) 0.77

Hepatitis C Virus Infection in Chronic Kidney Disease. J Am Soc Nephrol (2016) 0.76

Younger black patients have a higher risk of infection mortality that is mostly non-dialysis related: A national study of cause-specific mortality among U.S. maintenance dialysis patients. Hemodial Int (2016) 0.75

Early Results of Pilot Study Using Hepatitis C Virus (HCV) Positive Kidneys to Transplant HCV Infected Patients with End-Stage Renal Disease Allowing for Successful Interferon-Free Direct Acting Antiviral Therapy after Transplantation. Cureus (2016) 0.75

Chronic kidney disease: Treatment of hepatitis C virus infection in patients with CKD. Nat Rev Nephrol (2015) 0.75

Grazoprevir plus elbasvir and other treatment options in hepatitis C infected patients with stage 4-5 chronic kidney disease. Ann Transl Med (2016) 0.75

Risk of Cardiovascular Disease Due to Chronic Hepatitis C Infection: A Review. J Clin Transl Hepatol (2017) 0.75

Articles by these authors

Vascular endothelial growth factor regulates endothelial cell survival through the phosphatidylinositol 3'-kinase/Akt signal transduction pathway. Requirement for Flk-1/KDR activation. J Biol Chem (1998) 8.30

Vascular endothelial growth factor induces expression of the antiapoptotic proteins Bcl-2 and A1 in vascular endothelial cells. J Biol Chem (1998) 3.78

Complement functional tests for monitoring eculizumab treatment in patients with atypical hemolytic uremic syndrome. J Thromb Haemost (2014) 2.38

Meta-analysis of observational studies: hepatitis C and survival after renal transplant. J Viral Hepat (2013) 2.15

Proteolytic activation of the cell death protease Yama/CPP32 by granzyme B. Proc Natl Acad Sci U S A (1996) 1.90

Apoptosis induction by caspase-8 is amplified through the mitochondrial release of cytochrome c. J Biol Chem (1998) 1.86

Meta-analysis: interferon for the treatment of chronic hepatitis C in dialysis patients. Aliment Pharmacol Ther (2003) 1.82

A randomized study evaluating cinacalcet to treat hypercalcemia in renal transplant recipients with persistent hyperparathyroidism. Am J Transplant (2014) 1.73

Meta-analysis: levamisole improves the immune response to hepatitis B vaccine in dialysis patients. Aliment Pharmacol Ther (2010) 1.51

Meta-analysis: the effect of age on immunological response to hepatitis B vaccine in end-stage renal disease. Aliment Pharmacol Ther (2004) 1.33

The impact of hepatitis C virus infection on survival in dialysis patients: meta-analysis of observational studies. J Viral Hepat (2007) 1.27

mE10, a novel caspase recruitment domain-containing proapoptotic molecule. J Biol Chem (1999) 1.22

Extensive in vivo angiogenesis following controlled release of human vascular endothelial cell growth factor: implications for tissue engineering and wound healing. Artif Organs (2001) 1.18

Incidence of hip fracture in Rohtak district, North India. Arch Osteoporos (2013) 1.18

HBsAg seropositive status and survival after renal transplantation: meta-analysis of observational studies. Am J Transplant (2005) 1.15

Are laboratory tests useful for monitoring the activity of lupus nephritis? A 6-year prospective study in a cohort of 228 patients with lupus nephritis. Ann Rheum Dis (2008) 1.15

Meta-analysis: intradermal vs. intramuscular vaccination against hepatitis B virus in patients with chronic kidney disease. Aliment Pharmacol Ther (2006) 1.11

Antisense-mediated reduction in thrombospondin reverses the malignant phenotype of a human squamous carcinoma. J Clin Invest (1991) 1.10

Meta-analysis: anti-viral therapy of hepatitis C virus-related liver disease in renal transplant patients. Aliment Pharmacol Ther (2006) 1.09

Meta-analysis: Effect of hepatitis C virus infection on mortality in dialysis. Aliment Pharmacol Ther (2004) 1.09

Meta-analysis: anti-viral therapy of hepatitis B virus-associated glomerulonephritis. Aliment Pharmacol Ther (2006) 1.08

Meta-analysis: the adjuvant role of granulocyte macrophage-colony stimulating factor on immunological response to hepatitis B virus vaccine in end-stage renal disease. Aliment Pharmacol Ther (2006) 1.01

Opsoclonus--myoclonus syndrome in an adult: a case report and response to clonazepam. Indian J Ophthalmol (1996) 1.00

Histopathological features of hepatitis C in renal transplant candidates [see comment]. Transplantation (2000) 0.97

Effects of local continuous release of brain derived neurotrophic factor (BDNF) on peripheral nerve regeneration in a rat model. Exp Neurol (2006) 0.96

Monocyte killing of human squamous epithelial cells: role for thrombospondin. Cancer Res (1989) 0.95

Meta-analysis: the impact of diabetes mellitus on the immunological response to hepatitis B virus vaccine in dialysis patients. Aliment Pharmacol Ther (2011) 0.93

Biological dynamics of viral load in hemodialysis patients with hepatitis C virus. Am J Kidney Dis (2000) 0.93

Progressive improvement of patient and renal survival and reduction of morbidity over time in patients with lupus nephritis (LN) followed for 20 years. Lupus (2013) 0.93

Meta-analysis: terlipressin therapy for the hepatorenal syndrome. Aliment Pharmacol Ther (2006) 0.92

Automated RIBA hepatitis C virus (HCV) strip immunoblot assay for reproducible HCV diagnosis. J Clin Microbiol (1998) 0.91

Interferon monotherapy of chronic hepatitis C in dialysis patients: meta-analysis of clinical trials. J Viral Hepat (2008) 0.91

Antiviral therapy (pegylated interferon and ribavirin) of hepatitis C in dialysis patients: meta-analysis of clinical studies. J Viral Hepat (2014) 0.89

Meta-analysis: the dialysis mode and immunological response to hepatitis B virus vaccine in dialysis population. Aliment Pharmacol Ther (2006) 0.88

Tumor type-specific differences in cell-substrate adhesion among human tumor cell lines. Int J Cancer (1987) 0.87

The long-term prognosis of renal transplant in patients with systemic vasculitis. Am J Transplant (2007) 0.87

Oxidative stress and homocysteine metabolism in patients with lupus nephritis. Lupus (2009) 0.87

Thrombospondin 3 is a pentameric molecule held together by interchain disulfide linkage involving two cysteine residues. J Biol Chem (1995) 0.86

Detection of de novo hepatitis C virus infection by polymerase chain reaction in hemodialysis patients. Am J Nephrol (1999) 0.86

Quantitative assessment of HCV load in chronic hemodialysis patients: a cross-sectional survey. Nephron (1998) 0.86

Renal handling of sodium and water in early chronic liver disease. Evidence for a reduced natriuretic activity of the cirrhotic urinary extracts in rats. Gastroenterology (1981) 0.85

Cinacalcet reduces plasma intact parathyroid hormone, serum phosphate and calcium levels in patients with secondary hyperparathyroidism irrespective of its severity. Clin Nephrol (2011) 0.85

Intradermal vs intramuscular vaccine against hepatitis B infection in dialysis patients: a meta-analysis of randomized trials. J Viral Hepat (2010) 0.84

Transmission of hepatitis C virus infection in hemodialysis: current concepts. Int J Artif Organs (2008) 0.84

Review article: hepatitis C virus and calcineurin inhibition after renal transplantation. Aliment Pharmacol Ther (2005) 0.84

Carotid artery involvement in patients of atherosclerotic coronary artery disease undergoing coronary artery bypass grafting. Indian Heart J (2002) 0.84

Combined antiviral therapy of hepatitis C virus in dialysis patients: meta-analysis of clinical trials. J Viral Hepat (2010) 0.83

Acquisition of hepatitis C virus in hemodialysis patients: a prospective study by branched DNA signal amplification assay. Am J Kidney Dis (1998) 0.83

Interferon therapy of acute hepatitis C in dialysis patients: meta-analysis. J Viral Hepat (2012) 0.83

Epidemiology of Helicobacter pylori in chronic haemodialysis patients using the new RIBA H. pylori SIA. Nephrol Dial Transplant (1999) 0.82

Meta-analysis: the adjuvant role of thymopentin on immunological response to hepatitis B virus vaccine in end-stage renal disease. Aliment Pharmacol Ther (2006) 0.82

Inadequate diagnosis and therapy of arterial hypertension as causes of left ventricular hypertrophy in uremic dialysis patients. Kidney Int (2000) 0.82

Serotyping strip immunoblot assay for assessing hepatitis C virus strains in dialysis patients. Am J Kidney Dis (2000) 0.82

Decapitation in road traffic accident--a case report. Forensic Sci Int (2003) 0.81

Hepatitis C virus infection and post-transplant diabetes mellitus among renal transplant patients: a meta-analysis. Int J Artif Organs (2008) 0.81

Antiviral therapy of hepatitis C in chronic kidney diseases: meta-analysis of controlled clinical trials. J Viral Hepat (2008) 0.81

[Calcimimetics, phosphate binders, vitamin D and its analogues for treating secondary hyperparathyroidism in chronic kidney disease: guideline from the Italian Society of Nephrology]. G Ital Nefrol (2007) 0.80

A novel model of in vitro osteocytogenesis induced by retinoic acid treatment. Eur Cell Mater (2012) 0.80

In vitro slow release profile of endothelial cell growth factor immobilized within calcium alginate microbeads. Artif Cells Blood Substit Immobil Biotechnol (1995) 0.80

Prevalence of mosquito species in Chhura block of Raipur district of Chhattisgarh state. J Commun Dis (2008) 0.79

Hepatocyte attachment on biodegradable modified chitosan membranes: in vitro evaluation for the development of liver organoids. Artif Organs (1998) 0.78

Interferon therapy for HCV-associated glomerulonephritis: meta-analysis of controlled trials. Int J Artif Organs (2007) 0.78

Hepatitis C virus infection and glomerular disease. Minerva Urol Nefrol (2014) 0.78

Epidemiology and natural history of hepatitis G virus infection in chronic hemodialysis patients. Am J Nephrol (1999) 0.78

Functional renal involvement in normotensive patients with progressive systemic sclerosis: impaired sodium excretion during isotonic saline infusion. Arthritis Rheum (1981) 0.78

Hepatitis B virus infection in the dialysis population: current perspectives. Int J Artif Organs (2008) 0.78

Podocytes: a new player for glutamate signaling. Int J Biochem Cell Biol (2012) 0.78

Automated RIBA HCV strip immunoblot assay: a novel tool for the diagnosis of hepatitis C virus infection in hemodialysis patients. Am J Nephrol (2001) 0.77

Hepatitis C virus and the immunological response to hepatitis B virus vaccine in dialysis patients: meta-analysis of clinical studies. J Viral Hepat (2011) 0.77

125I-iothalamate and creatinine clearances in patients with chronic renal diseases. Nephron (1979) 0.77

Controlled release of endothelial cell growth factor from chitosan-albumin microspheres for localized angiogenesis: in vitro and in vivo studies. Artif Cells Blood Substit Immobil Biotechnol (1996) 0.76

Alginate microbead release assay of angiogenesis. Methods Mol Med (2001) 0.76

Impact of hemodialysis therapy on hepatitis C virus infection: a deeper insight. Int J Artif Organs (2009) 0.76

Renal tubular defects in recurring bilateral nephrolithiasis. Clin Nephrol (1976) 0.76

An unusual cause of gross hematuria, improved by recumbency. Kidney Int (2006) 0.75

[Renal osteodystrophy Guidelines]. G Ital Nefrol (2003) 0.75

Hyperbilirubinemia after liver transplantation: the role of coupled plasma filtration adsorption. Transplant Proc (2013) 0.75

Xenotransplantation of fetal porcine hepatocytes in rats using a tissue engineering approach. Artif Organs (1999) 0.75

Indoor resting density pattern of mosquito species in Fingeswar block of Raipur district in Chhattisgarh, central India. J Parasit Dis (2010) 0.75

Comparison of LMA Unique, Ambu laryngeal mask and Soft Seal laryngeal mask during routine surgical procedures. Eur J Anaesthesiol (2007) 0.75

Increased osteoprotegerin in Italian haemodialysis patients. Osteoporos Int (2006) 0.75

Reply to the letter by He et al. 'Meta-analysis of observational studies: hepatitis C and survival after renal transplant'. J Viral Hepat (2014) 0.75

Soluble liver extract as supplement to detoxification by hemoperfusion in liver failure. Int J Artif Organs (1981) 0.75

Hepatitis C virus infection and diabetes mellitus in end-stage renal disease: evidence of a negative association. Int J Artif Organs (2006) 0.75